Literature DB >> 8300049

Normal control of growth hormone secretion.

M L Hartman1, J D Veldhuis, M O Thorner.   

Abstract

Growth hormone (GH) is secreted by the anterior pituitary gland in a pulsatile fashion under the regulation of two hypothalamic peptides: GH-releasing hormone (GHRH) stimulates GH synthesis and secretion while somatostatin inhibits GH release. Studies in rats, sheep and humans indicate that whereas GHRH is required for the initiation of GH pulses, the amplitude of GH pulses is modulated by somatostatin. In humans, these interactions result in a pattern of volleys of GH-secretory pulses with intervening periods of relative secretory quiescence. The amplitude and frequency of GH-secretory pulses are regulated by a complex array of external and internal stimuli including age, gender, menstrual cycle phase, pubertal status, nutrition, sleep, body composition and exercise. Changes in plasma concentrations of gonadal hormones, insulin and insulin-like growth factor-I likely mediate the effects of several of these factors. A greater understanding of the physiology of GH secretion will enable the development of future strategies to enhance GH secretion in GH-deficient states including the use of GH secretagogues and modification of nutrition and exercise habits.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8300049     DOI: 10.1159/000183766

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  25 in total

1.  Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.

Authors:  Pamela U Freda; Carlos M Reyes; Abu T Nuruzzaman; Robert E Sundeen; Jeffrey N Bruce
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

2.  The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.

Authors:  J Bellone; S Bellone; G Aimaretti; M R Valetto; C Baffoni; G Corneli; C Origlia; E Arvat; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

3.  Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals.

Authors:  Nicholas J Justice; Amy L Blount; Emanuele Pelosi; David Schlessinger; Wylie Vale; Louise M Bilezikjian
Journal:  Mol Endocrinol       Date:  2011-06-23

4.  Revealing the large-scale network organization of growth hormone-secreting cells.

Authors:  Xavier Bonnefont; Alain Lacampagne; Angela Sanchez-Hormigo; Elodie Fino; Audrey Creff; Marie-Noelle Mathieu; Sébastien Smallwood; Danielle Carmignac; Pierre Fontanaud; Pierre Travo; Gérard Alonso; Nathalie Courtois-Coutry; Steve M Pincus; Iain C A F Robinson; Patrice Mollard
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-04       Impact factor: 11.205

Review 5.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 6.  Growth Hormone Deficiency and Excessive Sleepiness: A Case Report and Review of the Literature.

Authors:  Anisha Gohil; Erica Eugster
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 7.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 8.  Pitfalls in the biochemical assessment of acromegaly.

Authors:  Pamela U Freda
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

9.  Gender and age in the biochemical assessment of cure of acromegaly.

Authors:  P U Freda; R E Landman; R E Sundeen; K D Post
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

Review 10.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.